Analysis of information sources in references of the Wikipedia article "ACE2" in Hebrew language version.
{{cite web}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה)The discovery of ACE2 and its role in counteracting the effect of Ang-II through Ang(1-7) formation ... An imbalance in ACE2/Ang-(1–7) and ACE/Ang-II axes is critical in the development of cardiovascular diseases. The central role of ACE2, therefore, appears to counter ACE activity by reducing Ang-II bioavailability and increasing Ang(1-7) formation ... The use of RAS-modulating agents and molecules as novel therapeutic agents in hypertension and cardiovascular therapeutic research.
{{cite journal}}
: (עזרה)Studies with recombinant human ACE2 (rhACE2) have shown beneficial cardiac effects [18, 36]. rhACE2 has anti-fibrotic properties and can attenuate effect on systolic and diastolic dysfunction, presumably via Ang-II inhibition.
{{cite journal}}
: (עזרה)the possibility of using the A1-7 or ACE2 analogues, to enlarge current therapeutic options for AF, may represent an important field of research.
{{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה)Many α-coronaviruses utilize aminopeptidase N (APN) as their receptor, SARS-CoV and HCoV-NL63 use angiotensin-converting enzyme 2 (ACE2) as their receptor, MHV enters through CEACAM1, and the recently identified MERS-CoV binds to dipeptidyl-peptidase 4 (DPP4) to gain entry into human cells (See Table 1 for a list of known CoV receptors).
{{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה)Once SARS-CoV binds to its receptor, the abundance on the cell surface, mRNA expression and the enzymatic activity of ACE2 are significantly reduced. ... These effects are, in part, due to enhanced shedding/internalizing processes. ... The spike protein binds to ACE2 and subsequently down regulated ACE2 protein expression and resulted in worsened acid aspiration pneumonia
{{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה)Our results suggest an important role of ACE inhibitors, but not ARBs, in reducing the risk of pneumonia. These data may discourage the withdrawal of ACE inhibitors in some patients with tolerable adverse events (namely, cough) who are at particularly high risk of pneumonia. ACE inhibitors also lowered the risk of pneumonia related mortality, mainly in patients with established disease, but the robustness of the evidence was weaker.
{{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה)The discovery of ACE2 and its role in counteracting the effect of Ang-II through Ang(1-7) formation ... An imbalance in ACE2/Ang-(1–7) and ACE/Ang-II axes is critical in the development of cardiovascular diseases. The central role of ACE2, therefore, appears to counter ACE activity by reducing Ang-II bioavailability and increasing Ang(1-7) formation ... The use of RAS-modulating agents and molecules as novel therapeutic agents in hypertension and cardiovascular therapeutic research.
{{cite journal}}
: (עזרה)Studies with recombinant human ACE2 (rhACE2) have shown beneficial cardiac effects [18, 36]. rhACE2 has anti-fibrotic properties and can attenuate effect on systolic and diastolic dysfunction, presumably via Ang-II inhibition.
{{cite journal}}
: (עזרה)the possibility of using the A1-7 or ACE2 analogues, to enlarge current therapeutic options for AF, may represent an important field of research.
{{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה)Many α-coronaviruses utilize aminopeptidase N (APN) as their receptor, SARS-CoV and HCoV-NL63 use angiotensin-converting enzyme 2 (ACE2) as their receptor, MHV enters through CEACAM1, and the recently identified MERS-CoV binds to dipeptidyl-peptidase 4 (DPP4) to gain entry into human cells (See Table 1 for a list of known CoV receptors).
{{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה)Once SARS-CoV binds to its receptor, the abundance on the cell surface, mRNA expression and the enzymatic activity of ACE2 are significantly reduced. ... These effects are, in part, due to enhanced shedding/internalizing processes. ... The spike protein binds to ACE2 and subsequently down regulated ACE2 protein expression and resulted in worsened acid aspiration pneumonia
{{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה)Our results suggest an important role of ACE inhibitors, but not ARBs, in reducing the risk of pneumonia. These data may discourage the withdrawal of ACE inhibitors in some patients with tolerable adverse events (namely, cough) who are at particularly high risk of pneumonia. ACE inhibitors also lowered the risk of pneumonia related mortality, mainly in patients with established disease, but the robustness of the evidence was weaker.
{{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה)The discovery of ACE2 and its role in counteracting the effect of Ang-II through Ang(1-7) formation ... An imbalance in ACE2/Ang-(1–7) and ACE/Ang-II axes is critical in the development of cardiovascular diseases. The central role of ACE2, therefore, appears to counter ACE activity by reducing Ang-II bioavailability and increasing Ang(1-7) formation ... The use of RAS-modulating agents and molecules as novel therapeutic agents in hypertension and cardiovascular therapeutic research.
{{cite journal}}
: (עזרה)Studies with recombinant human ACE2 (rhACE2) have shown beneficial cardiac effects [18, 36]. rhACE2 has anti-fibrotic properties and can attenuate effect on systolic and diastolic dysfunction, presumably via Ang-II inhibition.
{{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה)Many α-coronaviruses utilize aminopeptidase N (APN) as their receptor, SARS-CoV and HCoV-NL63 use angiotensin-converting enzyme 2 (ACE2) as their receptor, MHV enters through CEACAM1, and the recently identified MERS-CoV binds to dipeptidyl-peptidase 4 (DPP4) to gain entry into human cells (See Table 1 for a list of known CoV receptors).
{{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה)Our results suggest an important role of ACE inhibitors, but not ARBs, in reducing the risk of pneumonia. These data may discourage the withdrawal of ACE inhibitors in some patients with tolerable adverse events (namely, cough) who are at particularly high risk of pneumonia. ACE inhibitors also lowered the risk of pneumonia related mortality, mainly in patients with established disease, but the robustness of the evidence was weaker.
{{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite web}}
: (עזרה)the possibility of using the A1-7 or ACE2 analogues, to enlarge current therapeutic options for AF, may represent an important field of research.
{{cite journal}}
: (עזרה){{cite news}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה)